CF Industries
CF NYSE Fertilizers & Agricultural Chemicals Financials FY2016βFY2025
CF Industries' revenue rose 19.3% to $7.1 billion in fiscal 2025. Its operating margin was 32.5%, up from 29.4% a year earlier. Free cash flow was $1.8 billion, up 2.8%. It paid out $1.7 billion in dividends and buybacks, 94% of free cash flow. The diluted share count fell 10.2%.
About these figures. Net income is the part that belongs to CF Industries' shareholders; its 10-Ks tag a total only with the share of the minority owner of its nitrogen business included.
What CF Industries does
No business description yet.
- Legal name
- CF INDUSTRIES HOLDINGS, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001324404-26-000007
0001324404
Revenue and margins
CF Industries had $7.1B of revenue in fiscal 2025, up 19.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.8B in fiscal 2025, 25.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
CF Industries returned $1.7B to shareholders in fiscal 2025, 94% of free cash flow. The diluted share count fell 10.2%.
Value CF Industries yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.2B and divides by 162.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 9.0x Β· peers 29.2x Β· sector 20.6x.
Balance sheet
Cash, debt and the ratios that show how comfortably CF Industries can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.6B | $2.3B | $2.0B | $1.6B | $2.0B |
| Debt incl. finance leases | $3.5B | $3.0B | $3.0B | $3.0B | $3.2B |
| Net debt / EBITDA | 0.7x | 0.1x | 0.3x | 0.5x | 0.4x |
| Debt / equity | 1.1x | 0.6x | 0.5x | 0.6x | 0.7x |
| Interest coverage | 9.4x | 15.7x | 14.9x | 14.4x | 14.8x |
| Current ratio | 1.8x | 3.7x | 3.8x | 3.1x | 3.4x |
| Quick ratio | 1.5x | 3.2x | 3.4x | 2.7x | 2.9x |
| Total assets | $12.4B | $13.3B | $14.4B | $13.5B | $14.1B |
| Total liabilities | $6.3B | $5.5B | $6.0B | $5.9B | $6.3B |
| Shareholders' equity | $3.2B | $5.1B | $5.7B | $5.0B | $4.8B |
| Net debt (β = net cash) | $1.8B | $642M | $936M | $1.4B | $1.2B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$23.8M
6 insiders
Of sales under plans
8%
$1.8M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Bert A FrostEVP, Chief Commercial Officer | Sold | 6,000 | $126.00 | $0.8M | Form 4 |
| Mar 17, 2026 | Erik M. MayerVP, Clean Energy & BusDevelop | Sold | 1,500 | $124.69 | $0.2M | Form 4 |
| Mar 17, 2026 | Richard A HokerVP and Corporate Controller | Sold | 3,499 | $125.38 | $0.4M | Form 4 |
| Mar 13, 2026 | Will W AnthonyDirector | Sold | 53,026 | $130.83 | $6.9M | Form 4 |
| Mar 12, 2026 | Bert A FrostEVP, Chief Commercial Officer | Sold | 6,250 | $136.69 | $0.9M | Form 4 |
| Mar 12, 2026 | Susan L MenzelEVP and Chief Admin. Officer | Sold | 18,041 | $136.06 | $2.5M | Form 4 |
| Mar 11, 2026 | Will W AnthonyDirector | Sold | 28,625 | $118.64 | $3.4M | Form 4 |
| Mar 9, 2026 | Bert A FrostEVP, Chief Commercial Officer | Sold plan | 5,534 | $116.21 | $0.6M | Form 4 |
| Mar 6, 2026 | Bert A FrostEVP, Chief Commercial Officer | Sold plan | 10,000 | $119.01 | $1.2M | Form 4 |
| Mar 6, 2026 | Erik M. MayerVP, Clean Energy & BusDevelop | Sold | 2,200 | $116.25 | $0.3M | Form 4 |
| Mar 6, 2026 | Michael Patrick McGraneSVP, Gen. Counsel & Secretary | Sold | 3,666 | $116.50 | $0.4M | Form 4 |
| Mar 5, 2026 | Will W AnthonyDirector | Sold | 57,364 | $109.35 | $6.3M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 6 / 9 | 5 / 9 | 8 / 9 |
| Accruals ratio | β8.9% | β7.6% | β9.4% |
| Altman Z'' | 4.56 | 4.03 | 4.26 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| CF Industries CF | $18.6B | 19.3% | 32.5% | 25.4% | 20.6% | 9.0x | 8 | |
| Mosaic MOS | $5.7B | 8.4% | 6.8% | β4.4% | 2.5% | β | 8 | Compare β |
| FMC FMC | $633M | β18.3% | β47.0% | β3.0% | β19.6% | β | 2 | Compare β |
| Scotts Miracle-Gro SMG | $3.5B | β3.9% | 10.5% | 8.0% | 13.4% | 50.3x | 6 | Compare β |
| Corteva CTVA | $8.3B | 2.9% | β | 16.2% | 5.8% | 8.2x | 8 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.7B | $4.1B | $4.4B | $4.6B | $4.1B | $6.5B | $11.2B | $6.6B | $5.9B | $7.1B |
| Gross profit | $843M | $434M | $917M | $1.2B | $801M | $2.4B | $5.9B | $2.5B | $2.1B | $2.7B |
| Operating income | $138M | $234M | $766M | $1.0B | $623M | $1.7B | $5.4B | $2.2B | $1.7B | $2.3B |
| Interest expense | $200M | $315M | $241M | $237M | $179M | $184M | $344M | $150M | $121M | $155M |
| Pretax income | β$226M | β$125M | $547M | $772M | $463M | $1.5B | $5.1B | $2.2B | $1.8B | $2.2B |
| Income tax | β$68.0M | β$575M | $119M | $126M | $31.0M | $283M | $1.2B | $410M | $285M | $441M |
| Net income | β$277M | $358M | $290M | $493M | $317M | $917M | $3.3B | $1.5B | $1.2B | $1.5B |
| Diluted EPS | β$1.19 | $1.53 | $1.24 | $2.23 | $1.47 | $4.24 | $16.38 | $7.87 | $6.74 | $8.97 |
| Diluted shares | 0.23B | 0.23B | 0.23B | 0.22B | 0.22B | 0.22B | 0.20B | 0.19B | 0.18B | 0.16B |
| Cash flow | ||||||||||
| Cash from operations | $617M | $1.6B | $1.5B | $1.5B | $1.2B | $2.9B | $3.9B | $2.8B | $2.3B | $2.8B |
| Capital expenditure | $2.2B | $473M | $422M | $404M | $309M | $514M | $453M | $499M | $518M | $950M |
| Free cash flow | β$1.6B | $1.2B | $1.1B | $1.1B | $922M | $2.4B | $3.4B | $2.3B | $1.8B | $1.8B |
| Depreciation and amortization | $678M | $883M | $888M | $875M | $892M | $888M | $850M | $869M | $925M | $898M |
| Stock-based compensation | $19.0M | $17.0M | $22.0M | $28.0M | $25.0M | $30.0M | $41.0M | $37.0M | $36.0M | $45.0M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $1.2B | $2.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $467M | $370M | $100M | $539M | $1.3B | $580M | $1.5B | $1.4B |
| Dividends paid | $280M | $280M | $280M | $265M | $258M | $260M | $306M | $311M | $364M | $326M |
| Dividends and buybacks | $280M | $280M | $747M | $635M | $358M | $799M | $1.7B | $891M | $1.9B | $1.7B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $1.2B | $835M | $682M | $287M | $683M | $1.6B | $2.3B | $2.0B | $1.6B | $2.0B |
| Total debt | $5.8B | $4.7B | $4.7B | $4.0B | $4.0B | $3.5B | $3.0B | $3.0B | $3.0B | $3.2B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $2.7B | $1.5B | $1.3B | $974M | $1.4B | $2.6B | $3.7B | $3.1B | $2.5B | $3.0B |
| Current liabilities | $686M | $580M | $705M | $665M | $906M | $1.4B | $995M | $800M | $818M | $887M |
| Inventory | $339M | $275M | $309M | $351M | $287M | $408M | $474M | $299M | $314M | $383M |
| Property and equipment, net | $9.7B | $9.2B | $8.6B | $8.2B | $7.6B | $7.1B | $6.4B | $7.1B | $6.7B | $6.7B |
| Total assets | $15.1B | $13.5B | $12.7B | $12.2B | $12.0B | $12.4B | $13.3B | $14.4B | $13.5B | $14.1B |
| Total liabilities | $8.6B | $6.8B | $6.9B | $6.5B | $6.4B | $6.3B | $5.5B | $6.0B | $5.9B | $6.3B |
| Shareholders' equity | $3.3B | $3.6B | $3.0B | $2.9B | $2.9B | $3.2B | $5.1B | $5.7B | $5.0B | $4.8B |
| Margins | ||||||||||
| Gross margin | 22.9% | 10.5% | 20.7% | 25.6% | 19.4% | 36.5% | 52.4% | 38.4% | 34.6% | 38.5% |
| Operating margin | 3.7% | 5.7% | 17.3% | 21.9% | 15.1% | 26.5% | 48.3% | 33.6% | 29.4% | 32.5% |
| EBITDA margin | 22.1% | 27.1% | 37.3% | 40.9% | 36.7% | 40.0% | 55.9% | 46.7% | 45.0% | 45.1% |
| Net margin | β7.5% | 8.7% | 6.6% | 10.7% | 7.7% | 14.0% | 29.9% | 23.0% | 20.5% | 20.5% |
| FCF margin | β43.3% | 28.0% | 24.3% | 24.0% | 22.4% | 36.1% | 30.4% | 34.1% | 29.5% | 25.4% |
| Returns | ||||||||||
| Return on capital | 1.1% | 1.7% | 5.9% | 8.8% | 6.4% | 16.9% | 51.0% | 20.5% | 16.0% | 20.6% |
| Return on capital employed | 1.1% | 1.7% | 6.2% | 8.6% | 5.5% | 15.7% | 46.4% | 17.2% | 13.3% | 17.8% |
| Return on equity | β7.5% | 10.3% | 8.9% | 16.8% | 10.9% | 29.9% | 81.1% | 28.3% | 22.8% | 29.6% |
| Return on assets | β2.0% | 2.5% | 2.2% | 4.0% | 2.6% | 7.5% | 26.1% | 11.0% | 8.8% | 10.6% |
| Growth | ||||||||||
| Revenue growth | β14.5% | 12.1% | 7.2% | 3.6% | β10.2% | 58.5% | 71.1% | β40.7% | β10.5% | 19.3% |
| Net income growth | β139.6% | β | β19.0% | 70.0% | β35.7% | 189.3% | 264.9% | β54.4% | β20.1% | 19.5% |
| EPS growth | β140.2% | β | β19.0% | 79.8% | β34.1% | 188.4% | 286.3% | β52.0% | β14.4% | 33.1% |
| FCF growth | β | β | β7.2% | 2.4% | β16.3% | 155.9% | 44.2% | β33.6% | β22.4% | 2.8% |
| Share count change | β1.3% | 0.3% | β0.0% | β5.2% | β2.9% | 0.5% | β5.6% | β5.1% | β6.8% | β10.2% |
| Financial health | ||||||||||
| Net debt / EBITDA | 5.7x | 3.5x | 2.4x | 2.0x | 2.2x | 0.7x | 0.1x | 0.3x | 0.5x | 0.4x |
| Debt / equity | 1.7x | 1.3x | 1.6x | 1.4x | 1.4x | 1.1x | 0.6x | 0.5x | 0.6x | 0.7x |
| Interest coverage | 0.7x | 0.7x | 3.2x | 4.2x | 3.5x | 9.4x | 15.7x | 14.9x | 14.4x | 14.8x |
| Current ratio | 3.9x | 2.5x | 1.8x | 1.5x | 1.5x | 1.8x | 3.7x | 3.8x | 3.1x | 3.4x |
| Quick ratio | 3.4x | 2.1x | 1.4x | 0.9x | 1.2x | 1.5x | 3.2x | 3.4x | 2.7x | 2.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 60.0% | 11.5% | 9.5% | 8.8% | 7.5% | 7.9% | 4.1% | 7.5% | 8.7% | 13.4% |
| Stock comp / revenue | 0.5% | 0.4% | 0.5% | 0.6% | 0.6% | 0.5% | 0.4% | 0.6% | 0.6% | 0.6% |
| Payouts / FCF | β | 24.2% | 69.5% | 57.7% | 38.8% | 33.9% | 48.6% | 39.5% | 106.9% | 93.8% |
| Quality scores | ||||||||||
| Piotroski F-score | 5.0 | 5.0 | 6.0 | 8.0 | 5.0 | 8.0 | 9.0 | 6.0 | 5.0 | 8.0 |
| Altman Z'' | 2.2 | 2.2 | 2.2 | 2.2 | 2.0 | 3.1 | 6.5 | 4.6 | 4.0 | 4.3 |
| Accruals ratio | β6.4% | β8.9% | β9.2% | β8.2% | β7.6% | β16.0% | β4.0% | β8.9% | β7.6% | β9.4% |
Source: SEC EDGAR XBRL filings (CIK 0001324404). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.